We caught up with people living with cancer across the country, to find out how the coronavirus pandemic has been affecting them and their families.

We spoke with Professor Kev Dhaliwal, chief investigator of the SPIKE-1 trial, about how repurposing a drug in a COVID-19 trial could benefit people with cancer.

Almost 20 years since Cancer Research UK was founded, not many who worked with McVie remain, but staff know him as the man who gave the charity its beginning.

A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice

There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services.

We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma.

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

Seven years after roll out began in England, bowel scope was still not being offered to everyone. And today, the test was removed from the roster.

More than 8 months since the pandemic began, we now have a clearer picture of how COVID-19 affects people with cancer.

Here’s what we know about how the new UK-EU relationship may affect cancer services and research.